• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于胰头腺癌,在Whipple手术前进行术前放疗是否能提高长期生存率?

Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?

作者信息

Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Iwanaga T, Matayoshi Y, Inoue T

机构信息

Department of Surgery, University of Osaka, Japan.

出版信息

Arch Surg. 1994 Oct;129(10):1075-80. doi: 10.1001/archsurg.1994.01420340089017.

DOI:10.1001/archsurg.1994.01420340089017
PMID:7944938
Abstract

OBJECTIVE

To determine whether or not both regional control and long-term survival rate were improved by preoperative irradiation prior to curative pancreatectomy for adenocarcinoma of the pancreatic head.

DESIGN

Retrospective study of recorded medical data from 1985 to 1989.

SETTING

The Center for Adult Diseases, Osaka, one of the major cancer centers in Japan.

PATIENTS AND INTERVENTION

Fifty-four consecutive patients in whom pancreatic head cancer had been judged to be resectable by preoperative diagnostic techniques. A total of 50 Gy per 10 MeV of x-ray was irradiated preoperatively to the wide field, including the pancreatic head area, in 23 patients (group A) but not in the 31 remaining patients (group B). The background factors before treatment did not differ between these two groups.

OUTCOME MEASURES

Resectability, postoperative survival, and modes of cancer recurrence.

RESULTS

At laparotomy, curative pancreatectomy was possible in 17 patients (74%) in group A and 19 (61%) in group B (not significant). In patients undergoing resection, the 1-year survival rate was 75% in group A and 43% in group B (P < .05). However, 3- and 5-year survival rates were almost the same in both groups (28% vs 32% and 22% vs 26%, respectively). With regard to the cause of death after pancreatectomy, group A had a significantly lower incidence of deaths due to regional recurrence within 1.5 postoperative years compared with group B, whereas deaths due to hepatic metastasis were markedly higher after 1 postoperative year in group A compared with group B.

CONCLUSIONS

Preoperative irradiation prior to pancreatectomy succeeded in reducing the incidence of early deaths due to regional recurrence. However, owing to the next barrier--death due to hepatic metastasis after 1 postoperative year--long-term (3- and 5-year) survival rate was not improved at all.

摘要

目的

确定术前放疗能否提高胰头腺癌根治性胰腺切除术后的区域控制率和长期生存率。

设计

对1985年至1989年记录的医疗数据进行回顾性研究。

地点

日本主要癌症中心之一的大阪成人疾病中心。

患者与干预措施

54例经术前诊断技术判断可切除胰头癌的连续患者。23例患者(A组)术前对包括胰头区域在内的广泛区域进行了每10兆电子伏X射线共50戈瑞的照射,其余31例患者(B组)未进行照射。两组治疗前的背景因素无差异。

观察指标

可切除性、术后生存率和癌症复发模式。

结果

剖腹手术时,A组17例患者(74%)可行根治性胰腺切除术,B组19例患者(61%)可行根治性胰腺切除术(无显著差异)。在接受切除术的患者中,A组1年生存率为75%,B组为43%(P<0.05)。然而,两组的3年和5年生存率几乎相同(分别为28%对32%和22%对26%)。关于胰腺切除术后的死亡原因,与B组相比,A组术后1.5年内因区域复发导致的死亡发生率显著较低,而与B组相比,A组术后1年以上因肝转移导致的死亡明显较高。

结论

胰腺切除术前的术前放疗成功降低了因区域复发导致的早期死亡发生率。然而,由于下一个障碍——术后1年以上因肝转移导致的死亡——长期(3年和5年)生存率根本没有提高。

相似文献

1
Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?对于胰头腺癌,在Whipple手术前进行术前放疗是否能提高长期生存率?
Arch Surg. 1994 Oct;129(10):1075-80. doi: 10.1001/archsurg.1994.01420340089017.
2
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.胰腺癌腺癌患者行胰十二指肠切除术后的术前和术后放化疗策略。
J Clin Oncol. 1997 Mar;15(3):928-37. doi: 10.1200/JCO.1997.15.3.928.
3
Extended pancreatectomy and liver perfusion chemotherapy for resectable adenocarcinoma of the pancreas.扩大胰切除术及肝灌注化疗治疗可切除胰腺癌
Digestion. 1999;60 Suppl 1:135-8. doi: 10.1159/000051470.
4
Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study.胰头癌标准胰切除术与扩大胰切除术的长期结局及复发模式:一项多中心前瞻性随机对照研究
J Hepatobiliary Pancreat Sci. 2017 Jul;24(7):426-433. doi: 10.1002/jhbp.465.
5
Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer.胰腺癌的胰切除术联合术中放射治疗
Ann Surg. 1997 Jul;226(1):66-9. doi: 10.1097/00000658-199707000-00009.
6
Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.胰腺导管腺癌胰腺切除术后五年生存者的临床和病理特征
World J Surg Oncol. 2014 Nov 27;12:360. doi: 10.1186/1477-7819-12-360.
7
Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.可切除胰腺癌术前放化疗的组织病理学反应:法国II期FFCD 9704-SFRO试验
Am J Clin Oncol. 2008 Dec;31(6):545-52. doi: 10.1097/COC.0b013e318172d5c5.
8
Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.术前肝脏磁共振成像对潜在可切除胰腺癌的辅助作用。
Surgery. 2017 Jun;161(6):1579-1587. doi: 10.1016/j.surg.2016.12.038. Epub 2017 Feb 23.
9
[Clinical comparison on the classical versus extensive Whipple's resection for adenocarcinoma of head of pancreas].[经典Whipple手术与扩大根治性Whipple手术治疗胰头腺癌的临床比较]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):575-8.
10
Whipple's operation for carcinoma of the pancreatic head and the ampullary region. Short-and long-term results.针对胰头和壶腹区域癌的惠普尔手术。短期和长期结果。
Scand J Gastroenterol. 1998 Jul;33(7):759-64. doi: 10.1080/00365529850171729.

引用本文的文献

1
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.新辅助治疗后与胰腺癌患者直接手术相比的免疫微环境。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14731-14743. doi: 10.1007/s00432-023-05219-7. Epub 2023 Aug 17.
2
Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy.诱导化疗及5次分割立体定向磁共振图像引导自适应放射治疗后初始无法手术切除的胰腺癌患者的死亡原因
Adv Radiat Oncol. 2022 Sep 25;8(1):101084. doi: 10.1016/j.adro.2022.101084. eCollection 2023 Jan-Feb.
3
Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer.
新辅助治疗改变了胰腺癌的免疫微环境。
Front Immunol. 2022 Sep 26;13:956984. doi: 10.3389/fimmu.2022.956984. eCollection 2022.
4
Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis.新辅助治疗与可切除胰腺癌的直接手术治疗:一项基于意向治疗和方案分析的系统评价和荟萃分析。
Sci Rep. 2019 Oct 30;9(1):15662. doi: 10.1038/s41598-019-52167-9.
5
Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse.机器学习算法在胰腺癌强化术前治疗中用于预测个体复发风险的应用
Cancers (Basel). 2019 Apr 30;11(5):606. doi: 10.3390/cancers11050606.
6
Intraoperative Radiation "Boost" to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report.胰十二指肠切除术后对可切除边界的胰腺癌手术切除床进行术中放疗“强化”:病例报告
Front Oncol. 2018 Mar 23;8:12. doi: 10.3389/fonc.2018.00012. eCollection 2018.
7
Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.胰腺癌:80年的手术——百分比与重复情况
HPB Surg. 2016;2016:6839687. doi: 10.1155/2016/6839687. Epub 2016 Oct 25.
8
Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach?新辅助治疗在胰腺癌患者中的应用:令人失望的治疗方法?
Cancers (Basel). 2011 May 9;3(2):2286-301. doi: 10.3390/cancers3022286.
9
An evaluation of neoadjuvant chemoradiotherapy for patients with resectable pancreatic ductal adenocarcinoma.可切除性胰腺导管腺癌患者新辅助放化疗的评估
HPB Surg. 2013;2013:298726. doi: 10.1155/2013/298726. Epub 2013 Jun 20.
10
Neoadjuvant therapy of pancreatic cancer: the emerging paradigm?胰腺癌的新辅助治疗:新兴范例?
Oncologist. 2012;17(2):192-200. doi: 10.1634/theoncologist.2011-0268. Epub 2012 Jan 16.